AAAAAA

   
Results: 1-8 |
Results: 8
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistancetesting
Authors: Lurain, NS Weinberg, A Crumpacker, CS Chou, SW
Citation: Ns. Lurain et al., Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistancetesting, ANTIM AG CH, 45(10), 2001, pp. 2775-2780
Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy
Authors: Zhang, JL Crumpacker, CS
Citation: Jl. Zhang et Cs. Crumpacker, Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy, J INFEC DIS, 184(10), 2001, pp. 1341-1344
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein
Authors: Zhang, JL Sharma, PL Crumpacker, CS
Citation: Jl. Zhang et al., Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein, VIROLOGY, 268(2), 2000, pp. 251-263
A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: A phase I study
Authors: Dezube, BJ Dahl, TA Wong, TK Chapman, B Ono, M Yamaguchi, N Gillies, SD Chen, LB Crumpacker, CS
Citation: Bj. Dezube et al., A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: A phase I study, J INFEC DIS, 182(2), 2000, pp. 607-610
Interstrain variation in the human cytomegalovirus DNA polymerase sequenceand its effect on genotypic diagnosis of antiviral drug resistance
Authors: Chou, SW Lurain, NS Weinberg, A Cai, GY Sharma, PL Crumpacker, CS
Citation: Sw. Chou et al., Interstrain variation in the human cytomegalovirus DNA polymerase sequenceand its effect on genotypic diagnosis of antiviral drug resistance, ANTIM AG CH, 43(6), 1999, pp. 1500-1502
Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val
Authors: Sharma, PL Crumpacker, CS
Citation: Pl. Sharma et Cs. Crumpacker, Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val, J VIROLOGY, 73(10), 1999, pp. 8448-8456
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Risultati: 1-8 |